دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Circulation Editors and Editorial Board.
doi : 10.1161/CIR.0000000000001169
Volume 148(1) pgs. 1-107,e1-e2 July 04, 2023
Myosin-Specific T Cells in Myocardial Diseases Revisited.
Ramos, Gustavo PhD; Frantz, Stefan MD; Hofmann, Ulrich MD
Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in a Population-Based Sample of US Children and Adolescents.
McEvoy, John W. MB BCh, MHS, PhD; Wang, Dan MS; Brady, Tammy MD, PhD; Tang, Olive MD, PhD; Ndumele, Chiadi E. MD, PhD; Coresh, Josef MD, PhD; Christenson, Robert H. PhD; Selvin, Elizabeth PhD, MPH
doi : 10.1161/CIRCULATIONAHA.122.063281
Myocardial injury is an important pediatric diagnosis. Establishing normative data from a representative pediatric sample is vital to provide accurate upper reference limits (URLs) for defining myocardial injury using high-sensitivity cardiac troponin.
Cardiac Troponin Reporting in Children and Young Adults: Time to Change Clinical Practice.
Aakre, Kristin M. MD, PhD; Meex, Steven J.R. PhD; Mills, Nicholas L. MD, PhD
Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.
Man, Shumei MD, PhD; Solomon, Nicole PhD; Mac Grory, Brian MB BCh BAO, MHSc, MRCP; Alhanti, Brooke PhD; Uchino, Ken MD; Saver, Jeffrey L. MD; Smith, Eric E. MD, MPH; Xian, Ying MD, PhD; Bhatt, Deepak L. MD, MPH; Schwamm, Lee H. MD; Hussain, Muhammad Shazam MD; Fonarow, Gregg C. MD
doi : 10.1161/CIRCULATIONAHA.123.064053
Existing data and clinical trials could not determine whether faster intravenous thrombolytic therapy (IVT) translates into better long-term functional outcomes after acute ischemic stroke among those treated with endovascular thrombectomy (EVT).
Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry.
Turagam, Mohit K. MD; Neuzil, Petr MD PhD; Schmidt, Boris MD; Reichlin, Tobias MD; Neven, Kars MD; Metzner, Andreas MD; Hansen, Jim MD; Blaauw, Yuri MD; Maury, Philippe MD; Arentz, Thomas MD; Sommer, Philipp MD; Anic, Ante MD; Anselme, Frederic MD; Boveda, Serge MD, PhD; Deneke, Tom MD; Willems, Stephan MD; van der Voort, Pepijn MD; Tilz, Roland MD; Funasako, Moritoshi MD; Scherr, Daniel MD; Wakili, Reza MD; Steven, Daniel MD; Kautzner, Josef MD; Vijgen, Johan MD; Jais, Pierre MD; Petru, Jan MD; Chun, Julian MD; Roten, Laurent MD; Futing, Anna MD; Lemoine, Marc D. MD; Ruwald, Martin MD; Mulder, Bart A MD; Rollin, Anne MD; Lehrmann, Heiko MD; Fink, Thomas MD; Jurisic, Zrinka MD; Chaumont, Corentin MD; Adelino, Raquel MD; Nentwich, Karin MD; Gunawardene, Melanie MD; Ouss, Alexandre MD; Heeger, Christian-Hendrik MD; Manninger, Martin MD; Bohnen, Jan-Eric MD; Sultan, Arian MD; Peichl, Petr MD; Koopman, Pieter MD; Derval, Nicolas MD; Kueffer, Thomas MD; Rahe, Gilbert MD; Reddy, Vivek Y. MD
doi : 10.1161/CIRCULATIONAHA.123.064959
Pulsed field ablation is a novel nonthermal cardiac ablation modality using ultra-rapid electrical pulses to cause cell death by a mechanism of irreversible electroporation.
INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10.
Zhang, Wei PhD *,; Zhao, Jinjing MD, PhD *,; Deng, Lin PhD; Ishimwe, Nestor PhD; Pauli, Jessica MSc; Wu, Wen PhD; Shan, Shengshuai MD, PhD; Kempf, Wolfgang PhD; Ballantyne, Margaret D. PhD; Kim, David BS; Lyu, Qing PhD; Bennett, Matthew PhD; Rodor, Julie PhD; Turner, Adam W. PhD; Lu, Yao Wei PhD; Gao, Ping PhD; Choi, Mihyun PhD; Warthi, Ganesh PhD; Kim, Ha Won PhD; Barroso, Margarida M. PhD; Bryant, William B. PhD; Miller, Clint L. PhD; Weintraub, Neal L. MD; Maegdefessel, Lars MD, PhD; Miano, Joseph M. PhD; Baker, Andrew H PhD; Long, Xiaochun PhD
doi : 10.1161/CIRCULATIONAHA.123.063760
Activation of vascular smooth muscle cell (VSMC) inflammation is vital to initiate vascular disease. The role of human-specific long noncoding RNAs in VSMC inflammation is poorly understood.
Early Diagnosis and Treatment Key for Cardiac Amyloidosis Outcomes.
Kuehn, Bridget M.
Inducibility of Short-Coupled Purkinje Ectopy by Pharmacological Tests in Patients With Spontaneous Short-Coupled Idiopathic Ventricular Fibrillation.
Haissaguerre, Michel MD; Duchateau, Josselin MD, PhD; Laredo, Mikael MD; Lavergne, Thomas MD; Winum, Pierre F. MD; Cheniti, Ghassen MD; Waintraub, Xavier MD; Samson, Sophie BSc; Surget, Elodie MD, PhD; Tixier, Romain MD; Sacher, Frederic MD, PhD; Marijon, Eloi MD, PhD; Bernus, Olivier PhD; Gandjbakhch, Estelle MD, PhD
Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy".
Monda, Emanuele MD; Limongelli, Giuseppe MD, PhD
Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
Kwan, Tak W. MD, FAHA, Chair; Wong, Sally S. PhD, RD, CDN, FAHA; Hong, Yuling MD, PhD, FAHA; Kanaya, Alka M. MD, FAHA; Khan, Sadiya S. MD, Msc, FAHA; Hayman, Laura L. PhD, RN, FAHA; Shah, Svati H. MD, MHS, FAHA; Welty, Francine K. MD, FAHA; Deedwania, Prakash C. MD, FAHA; Khaliq, Asma MD; Palaniappan, Latha P. MD, MS, Vice Chair; on behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine
doi : 10.1161/CIR.0000000000001145
AB Asian American individuals make up the fastest growing racial and ethnic group in the United States. Despite the substantial variability that exists in type 2 diabetes and atherosclerotic cardiovascular disease risk among the different subgroups of Asian Americans, the current literature, when available, often fails to examine these subgroups individually.
Digital Technologies in Cardiac Rehabilitation: A Science Advisory From the American Heart Association.
Golbus, Jessica R. MD, MS, Chair; Lopez-Jimenez, Francisco MD, MSc, FAHA, Vice Chair; Barac, Ana MD, PhD, FAHA; Cornwell, William K. III MD, MS, FAHA; Dunn, Patrick PhD, FAHA; Forman, Daniel E. MD, FAHA; Martin, Seth S. MD, MHS, FAHA; Schorr, Erica N. PhD, RN, FAHA; Supervia, Marta MD, MSc, PhD; on behalf of the Exercise, Cardiac Rehabilitation and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing
doi : 10.1161/CIR.0000000000001150
AB Cardiac rehabilitation has strong evidence of benefit across many cardiovascular conditions but is underused. Even for those patients who participate in cardiac rehabilitation, there is the potential to better support them in improving behaviors known to promote optimal cardiovascular health and in sustaining those behaviors over time
Correction to: KIDS SAVE LIVES: Basic Life Support Education for Schoolchildren: A Narrative Review and Scientific Statement From the International Liaison Committee on Resuscitation.
Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
